Circulating tumor DNA (ctDNA) monitoring to inform maintenance outcomes in patients (pts) with advanced NSCLC treated with induction atezolizumab plus carboplatin plus nabpaclitaxel (A plus CnP) Meeting Abstract

Industry Collaboration

cited authors

  • Pellini, Bruna; Madison, Russell; Childress, Merrida; Miller, Shoshana T.; Cheng, Jason H.; Huang, Richard S. P.; Krainock, Michael; Gupta, Pratyush; Zou, Wei; Shames, David S.; Moshkevich, Solomon; Ballinger, Marcus; Liu, Minetta C.; Young, Amanda; Srivastava, Minu K.; Oxnard, Geoffrey R.; Socinski, Mark A.

Publication Date

  • June 1, 2023

webpage

published in

category

volume

  • 41

issue

  • 16